However, there are some studies that argue for stimulatory action of ECs and synthetic CB1R agonists in insulin secretion, at least with supraphysiological levels, that possibly plays a role in hyperinsulinemia as seen in obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.